Apellis Pharmaceuticals Ownership | Who Owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Ownership Summary
Apellis Pharmaceuticals is owned by 68.13% institutional investors, 13.64% insiders, and 18.23% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 9.70% of APLS shares. Vanguard Health Care Inv is the top mutual fund, with 4.94% of its assets in Apellis Pharmaceuticals shares.
APLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apellis Pharmaceuticals | 68.13% | 13.64% | 18.23% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 12.22M | 9.70% | $276.59M |
| Vanguard group | 9.99M | 7.92% | $226.01M |
| Morgan stanley | 9.64M | 7.65% | $218.23M |
| Wellington management group llp | 9.29M | 7.37% | $210.25M |
| Deep track capital, lp | 8.00M | 6.35% | $181.05M |
| Blackrock funding, inc. /de | 6.27M | 4.97% | $141.86M |
| Blackrock | 5.80M | 4.71% | $222.31M |
| Jennison associates | 4.35M | 3.45% | $98.40M |
| State street | 4.04M | 3.20% | $91.37M |
| Ecor1 capital | 3.45M | 2.74% | $78.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Deep track capital, lp | 8.00M | 5.05% | $181.05M |
| Ecor1 capital | 3.45M | 3.74% | $78.01M |
| Avoro capital advisors | 12.22M | 3.58% | $276.59M |
| Boxer capital | 1.73M | 3.49% | $66.21M |
| Octagon capital advisors lp | 903.50K | 3.10% | $20.45M |
| Siren | 2.58M | 2.28% | $58.35M |
| Suvretta capital management | 2.88M | 1.67% | $65.13M |
| Ghost tree capital | 135.00K | 1.62% | $5.18M |
| Artal group | 1.47M | 1.43% | $56.28M |
| Camber capital management lp | 850.00K | 1.38% | $14.71M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jennison associates | 4.35M | 0.06% | 1.69M |
| Polar capital | 2.65M | 0.29% | 1.30M |
| Norges bank | 1.09M | 0.00% | 1.09M |
| Aqr capital management | 1.86M | 0.08% | 1.04M |
| Deep track capital, lp | 8.00M | 5.05% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 3.45M | 3.74% | -8.45M |
| Marshall wace, llp | 396.74K | 0.01% | -2.31M |
| Fiera capital | - | - | -1.35M |
| Ubs group | 3.43M | 0.01% | -1.31M |
| Cibc world markets | - | - | -1.29M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.09M | 0.00% | 1.09M | $34.66M |
| Camber capital management lp | 850.00K | 1.38% | 850.00K | $14.71M |
| Kynam capital management, lp | 808.61K | 1.36% | 808.61K | $18.30M |
| Los angeles capital management | 620.79K | 0.05% | 620.79K | $14.05M |
| Cubist systematic strategies | 299.78K | 0.03% | 299.78K | $6.78M |
Sold Out
| Holder | Change |
|---|---|
| Jfs wealth advisors | -1.00 |
| Concourse financial group securities | -1.00 |
| Creative financial designs inc /adv | -5.00 |
| Fortitude family office | -6.00 |
| Corecap advisors | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 223 | -14.56% | 85,860,587 | -25.21% | 68 | 0.82% | 108 | -27.52% | 72 | 10.77% |
| Jun 30, 2025 | 273 | -0.36% | 131,534,068 | 4.01% | 104 | 1.03% | 151 | 11.03% | 69 | -13.75% |
| Mar 31, 2025 | 6 | -97.89% | 12,635,786 | -90.03% | 10 | 0.10% | 2 | -98.73% | 1 | -98.68% |
| Dec 31, 2024 | 99 | -66.10% | 25,361,392 | -78.34% | 20 | 0.23% | 57 | -59.57% | 27 | -71.28% |
| Sep 30, 2024 | 291 | 2.46% | 117,076,868 | 1.49% | 94 | 1.09% | 142 | -12.35% | 93 | 43.08% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 6.24M | 4.94% | -3.04M |
| Vanguard Total Stock Mkt Idx Inv | 3.36M | 2.66% | -70.87K |
| Vanguard US Total Market Shares ETF | 3.30M | 2.63% | 2.68K |
| Vanguard Small Cap Index | 2.59M | 2.05% | -16.82K |
| SPDR® S&P Biotech ETF | 1.76M | 1.39% | 3.92K |
| Vanguard Small Cap Growth Index Inv | 1.47M | 1.16% | -725.00 |
| JPM US Mid Cap Growth-Composite | 1.30M | 1.07% | 294.66K |
| Polar Capital Biotech S Inc | 1.35M | 1.07% | - |
| JPMorgan Mid Cap Growth I | 1.30M | 1.05% | - |
| DWS Vermögensbildungsfonds I LD | 1.32M | 1.05% | 4.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2025 | Watson David O. | General Counsel | Sell | $100.30K |
| Oct 21, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $280.30K |
| Oct 16, 2025 | Watson David O. | General Counsel | Sell | $126.10K |
| Oct 10, 2025 | Dunlop A. Sinclair | - | Sell | $737.54K |
| Sep 30, 2025 | Dunlop A. Sinclair | - | Sell | $702.06K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 15 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 43 |
| 2024 Q4 | - | 2 |
APLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools